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Background: Pancreatic pseudocyst (PP) and walled-off necrosis can be managed endoscopically,
percutaneously or surgically, but with diverse efﬁcacy.
Aims &methods: A comprehensive literature search was carried out from inception to December 2018, to
identify articles which compared at least two of the three kinds of treatment modalities, regarding the
mortality, clinical success, recurrence, complications, cost and length of hospitalisation (LOH).
Results: The outcomes of endoscopic (ED) and percutaneous drainage (PD) were comparable in six ar-
ticles. The clinical success of endoscopic intervention was better considering any types of ﬂuid collections
(OR¼ 3.36; 95% conﬁdence interval (CI) 1.48, 7.63; p¼ 0.004). ED was preferable regarding recurrence of
PP (OR¼ 0.23; 95% CI 0.08, 0.66; p¼ 0.006). Fifteen articles compared surgical intervention with ED.
Signiﬁcant difference was found in postoperative LOH (WMD (days)¼4.61; 95%CI -7.89, 1.33;
p¼ 0.006) and total LOH (WMD (days)¼3.67; 95%CI -5.00, 2.34; p < 0.001) which favored endoscopy,
but ED had lower rate of clinical success (OR¼ 0.54; 95% CI 0.35, 0.85; p¼ 0.007) and higher rate of
recurrence (OR¼ 1.80; 95% CI 1.16, 2.79; p¼ 0.009) in the treatment of PP. Eleven studies compared
surgical and percutaneous intervention. PD resulted in higher rate of recurrence (OR¼ 4.91; 95% CI 1.82,
13.22; p¼ 0.002) and lower rate of clinical success (OR¼ 0.13; 95% CI 0.07, 0.22, p< 0.001).
Conclusion: Both endoscopy and surgery are preferable over percutaneous intervention, furthermore
endoscopic treatment is associated with shorter hospitalisation than surgery.
© 2019 IAP and EPC. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
One of the most frequent gastrointestinal disorders are the
different forms of pancreatitis [1,2]. The annual incidence of acute
and chronic pancreatitis ranges from 13 to 100/100.000 persons
and 5 to 25/100.000 persons, respectively [3]. Acute inﬂammation
of the pancreas could affect the quality of life through itsersity of Pecs, Medical School,
gy, First Department of Med-
., 7624, Pecs, Hungary
B.V. This is an open access article ucomplications for long term [1,4,5]. Among these complications the
management of peri- and/or intrapancreatic ﬂuid collections is still
a challenge.
Inﬂammatory ﬂuid collections of the pancreas could be cate-
gorized according to the 2012 Revised Atlanta classiﬁcation.
Pancreatic pseudocysts (PP) are well circumscribed collections of
ﬂuid in the pancreas, they develop most often several weeks after
an attack of acute pancreatitis. Walled-off necrosis (WON) origi-
nates from necrotizing pancreatitis; it needs four weeks to develop
and contains necrotic tissue [6]. Up to 20% of the patients, suffering
from acute pancreatitis, may develop PP, while it can occur up to
40% in the cases of chronic pancreatitis [7].
Both PP and WON need to be treated if they are symptomatic or
there is a proven or strongly suspected infection. The appearance ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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scopic drainage (ED), minimal invasive surgery) provided a wider
range of applicable methods. In some cases, the decision between
these modalities is obvious, because of the location of the collec-
tion, while in other cases similar short-term outcomes can be ex-
pected from different modalities. The European Society of
Gastrointestinal Endoscopy and the American Society of Gastroin-
testinal Endoscopy recommend ED or PD of infected WON as the
ﬁrst interventional method [8,9].
PD should be carried out through retroperitoneal access, with
real-time imaging, where ultrasonography (US) is preferred over
computed tomography (CT). ED incorporates many techniques
(transpapillary or transmural endoscopic drainage usually with
endoscopic ultrasound (EUS) guidance, transluminal endoscopic
necrosectomy). The endoscopic intervention can be also applied as
a step-up approach after percutaneous drainage [10]. The surgical
approach contains traditional open necrosectomy or minimally
invasive surgical necrosectomy. Hybrid interventions are also
applicable in some cases [8].
The aim of this meta-analysis is to compare the three main
modalities (ED vs. PD vs. surgical drainage (SD)) in the treatment of
pancreatic ﬂuid collections.
Methods
A meta-analysis was carried out using the population-
intervention-control-outcomes (PICO) format. Those studies were
selected where patients with PP or WON (P) were treated with
surgical, percutaneous or endoscopic drainage (I and C) and at least
two treatment modalities were compared. Mortality, clinical suc-
cess, recurrence, complications, length of hospitalisation (LOH)
were compared, as the outcomes of different treatment groups (O).
The meta-analysis was reported in accordance with the
Preferred Reporting Items for Systematic Review (PRISMA) state-
ment [11], and it was registered in advance in the PROSPERO
database (registration number: CRD42018079200).
Search strategy
The electronic databases of PubMed and Embase were system-
atically searched for relevant studies from inception to December
2018. The search included the following keywords: (”pancreatic
pseudocyst” OR “walled off necrosis”) AND (” drainage” OR “sur-
gery” OR” percutaneous” OR” endoscopy”) AND (“drainage” OR
“surgery”OR “percutaneous”OR “endoscopy”). The following ﬁlters
were applied: language: English, date of publication: from 1990 to
December 2018.
Inclusion and exclusion criteria
Articles were included if they provided data on at least two of
the three treatment modalities on patients with either PP or WON
or both reporting the outcomes mentioned above. PP and WON of
common etiologies were included, articles focusing on post-
surgical or traumatic ﬂuid collections were excluded. Prospective
and retrospective controlled observational studies, as well as ran-
domized controlled trials were selected. Conference abstracts with
sufﬁcient data were also included. Non-English language studies,
studies published before 1990, studies focusing on pediatric cases
and studies with combined interventions were excluded.
Selection process
The publications were processed by the EndNote X7.4 software
(Clarivate Analytics, Philadelphia, PA, USA). Duplications were
removed, the remaining records were screened ﬁrst by title, second
by abstract, ﬁnally by full-text by two independent authors.Data extraction
Numeric data were extracted into an Excel 2010 (Ofﬁce 365,
Microsoft, Redmond,WA, USA) sheet designed for this purpose. The
investigators (LS and AV) extracted the number of subjects,
methods of drainage, mortality, clinical success rate, recurrence,
complications, postoperative and total LOH, and cost of the treat-
ment from each publication independently, and then validated
these data. Disagreements were discussed and resolved by
consensus in plenum.
Statistical methods
Pairwise comparison between ED, PD and SD were carried out
with the outcomes of recurrence, complications, mortality, clinical
success and LOH. For binary and continuous outcomes, odds ratios
(OR) and weighted mean differences (WMD) with 95% conﬁdence
intervals (CI) were calculated with the random effect model (Der-
Simonian and Laird estimation) and displayed on forest plots. Sta-
tistical heterogeneity was analysed using the I2 statistic and the
chi2-test to gain probability-values; p< 0.1 was deﬁned to indicate
signiﬁcant heterogeneity. Where mean with standard deviation
was not reported for LOH, they were estimated from median,
interquartiles and range by using the method of Xiang Wan (2014)
[12].
Quality assessment of the studies included
The quality assessment of the articles was carried out by two
authors independently (LS and AV), with the Newcastle-Ottawa
Scale [13] for cohort and case-control studies and by using the
Jadad score [14] in the cases of randomized controlled trials
(RCTs).Supplemental Multimedia Component 1 and 2 presents the
results of the quality assessment.
Subgroup analysis
One of our further goal was to carry out an analysis regarding
only WON and PP. We also compared endoscopic intervention with
minimal invasive surgery, hypothesizing that minimal invasive
surgery provides better results, than open surgery.
Assessment of the grade of evidence
The GRADE system was used to assess the strength of recom-
mendation and quality of evidence of our results. GRADE stands for
Grades of Recommendation Assessment, Development, and Eval-
uation [15].
Results
Results of the selection process
We identiﬁed 1341 and 2863 articles in the Embase and PubMed
databases, respectively. Finally, 25 relevant articles were included
in the quantitative synthesis of this meta-analysis (Supplemental
Figure 1).
Charasteristics of the studies included
Among the 24 articles, ﬁve records were available only in the
form of conference abstracts. Two prospective observational
studies, two randomized controlled trials and 20 retrospective
observational studies were included in the quantitative synthesis.
The characteristics of the studies, details of endoscopic
L. Szako et al. / Pancreatology 20 (2020) 132e141134methodology, deﬁnition of clinical success and duration of follow-
up are shown in Table 1, while the demographics of the patients and
the details of ﬂuid-collections are listed in Table 2.Comparison of endoscopic drainage, percutaneous drainage
and surgical drainage
Percutaneous drainage versus endoscopic drainage
Pseudocysts and walled-off necroses
Six studies compared ED and PD (including 688 and 286 pa-
tients, respectively) [16e21]. Among these, four compared the
recurrence of the pseudocyst/WON [16e19], three the complica-
tions [16,18,20], two the mortality [16,17], four the clinical success
[16,19e21] and two the postoperative LOH [16,20].
ED has signiﬁcantly higher rate of clinical success (OR¼ 3.36;Table 1
Description of the studies selected regarding the study-design and the number of patient
yes, N: no.
Study Study design Number of
patients
Description of endoscopic meth
ED PD SD
Adams et al., 1992 retrospective e 52 42 N/A
Akshintala
et al 2014
retrospective 41 40 e conventional transmural
drainage [12] or
EUS-assisted transmural
drainage [29]
Barthet et al 1993 retrospective 54 39 29 pancreatic sphincterotomy
and dilatation
of the pancreatic strictures
Bopanna et al 2017* RCT 30 e 30 with or without EUS drainage,
necrosectomy
Heider et al 1999 retrospective e 66 66 N/A
Johnson et al 2009 retrospective 24 7 30 transmural drainage with or wi
transpapillary drainage
Keane et al 2015 retrospective 109 55 e EUS-guided transmural drainag
double pigtail stents
Khreiss et al 2015 retrospective 20 e 20 cystogastrostomy, double
pigtail or SEMS
Kumar et al 2014 prospective 12 12 e not deﬁned
Melman et al 2008 retrospective 45 e 38 cystogastrostomy,
double-pigtail stents
Morton et al 2005 retrospective e 8121 6409 N/A
Naoum et al 2003 retrospective e 3 9 N/A
Nealon et al 2002 retrospective e 50 148 N/A
Nq et al 1998 retrospective e 17 13 N/A
Pan et al 2015 retrospective 410 13 377 transmural drainage
Rana et al 2015 retrospective 26 e 25 EUS-guided transmural drainag
Redwan et al 2017 prospective 35 e 36 transmural or transpapillary
drainage
Saluja et al 2016* retrospective 35 e 20 cystogastrostomy
Saul et al 2015 retrospective 21 e 43 EUS-guided drainage,
double pigtail stents
Siddiqui et al 2017* retrospective 42 e 39 EUS-guided cystogastrostomy
Spofford et al 2011* retrospective 12 e 15 not reported
Tan et al 2018* retrospective 48 135 164 not reported
Varadarajulu
et al 2013
RCT 20 e 20 cystogastrostomy
Varadarajulu
et al 2008
retrospective 20 e 10 EUS-guided cystogastrostomy
P
1004 8610 758395% CI 1.48, 7.63; p¼ 0.004, I2¼ 68.9%, p¼ 0.022) than PD (Fig.1/A).
Mortality (OR¼ 0.26; 95% CI 0.01, 4.55; p¼ 0.353, I2¼ 58.5%,
p¼ 0.0121), occurrence of adverse events (OR¼ 1.36; 95% CI 0.52,
3.56; p¼ 0.531, I2¼18.6%, p¼ 0.293), recurrence (OR¼ 0.37; 95% CI
0.10, 1.38; p¼ 0.138, I2¼ 66.4%, p¼ 0.03) and LOH (weighted mean
difference (WMD) (days)¼ –30.58; 95% CI -74.87, 13.71; p¼ 0.009,
I2¼ 98%, p< 0.001) did not differ signiﬁcantly between the two
methods (Fig. 1/A, Supplemental Figure 2)Pseudocysts
Five articles compared ED and PD regarding pseudocysts (in 579
and 231 patients, respectively) [17e21]. Among these, one article
compared the mortality [17], three the recurrence [17e19], three
the clinical success [19e21], two the complications [18,20] and one
the LOH [20]. Rate of recurrence (OR¼ 0.23; 95% CI 0.08, 0.66;
p¼ 0.006, I2¼ 35.1%, p¼ 0.214) showed a signiﬁcant differences. Conference abstracts are indicated with *. N/A: not applicable, NR: not relevant, Y:
ods Endoscopic
necrosectomy
(Y/N)
Deﬁnition of clinical success Follow-up
N/A N/A N/A
N Reduction in size to 50% of initial
size and resolution of symptoms
Endoscopic drainage:
909 days
Percutaneous drainage:
671 days
N N/A N/A
Y Complete resolution of the cyst 22 months
N/A Rediographic resolution or
resolution of the symptoms
N/A
thout N Complete resolution of the
ﬂuid collection
Endoscopy: 10 months
Surgery: 15 months
e, N Complete resolution,
or decrease in size to <2 cm
Endoscopy: 11 months
(median)
Percutaneous drainage:
17 months (median)
N Lack of need for re-intervention Endoscopy: 16 months
Surgery: 6 months
Y Resolution of symptoms Endoscopy: 1.9 year
Surgery 2.8 year
N Symptom or cyst resolution NR
N/A N/A N/A
N/A N/A N/A
N/A N/A N/A
N/A Pseudocyst resolution N/A
N Pseudocyst resolution N/A
e Y Pseudocyst resolution,
and asymptomatic patient
Endoscopy: 22.3 months
Surgery: 31 months
N Clinical or radiological resolution At least 6 months
N N/A N/A
N Complete resolution or
decrease of the size of the
cyst to 2 cm or smaller
Endoscopy: 270 days
(median)
Surgery: 580 days
(median)
N Absence of failure N/A
Y Resolution of symptoms Endoscopy: 13.4 months
Surgery: 38.5 months
not reported Pseudocyst resolution At least 3 months
N Clinical resolution of symptoms
and radiological resolution
24 months
N Clinical resolution of symptoms
and radiological resolution
At least 3 months
Table 2
Description of the demographic characteristics of the patients and the ﬂuid-collections. (ED: endoscopic drainage, PD: percutaneous drainage, SD: surgical drainage, M/F:
male-female, L: laparoscopic subgroup, O: open surgery subgroup, H:head, B:body, T:tail, P: peripancreatic, E: entire gland, U: uncinate, EP: extrapancreatic, M: multiple, NR:
not reported).
Study Sex (M/F ratio) Age (mean; years) Size of the cyst (mean; cm) Location of the cyst Number of
patients with
WON
ED PD SD ED PD SD ED PD SD ED PD SD ED PD SD
Adams et al., 1992 e 44/8 29/13 e 43.2 45.5 e NR NR e H:
13
B:29
T:10
H:12
B:23
T:7
e 0 0
Akshintala et al 2014 28/13 26/14 e 47.1 52.7 e 9.5 9.4 e H: 9
B: 14
T: 20
P: 14
H:
15
B:
15
T:
12
P:
19
e 0 0 e
Barthet et al 1993 125/18 (all pt) NR NR NR NR NR NR H: 115
B: 33
T: 21
EP: 1
0 0 0
Heider et al 1999 e 41/25 45/21 41 (all pt) e 8.2 7.4 e NR NR e 0 0
Johnson et al 2009 NR NR NR 52 NR 49 9.5 NR 9.1 NR NR NR 0 0 0
Keane et al 2015 60/49 37/18 e NR NR e NR NR e H: 41
B-T: 68
e H: 20
B-T:
35
38 30 e
Khreiss et al 2015 9/11 e 16/4 NR e NR 11.2 e 15.2 H: 5
B: 11
T: 5
E: 2
H: 3
B: 15
T: 10
E: 4
20 e 20
Kumar et al 2014 8/4 9/3 e 58.9 53.3 e 1306mL 1354mL e NR NR e 12 12 e
Melman et al 2008 1.4 e NR 51.8 e NR 9.1 e NR NR e NR 0 e 0
Morton et al 2005 e 58% 59% e 53 51 e NR NR e NR NR e 0 0
Naoum et al 2003 e 2/1 3/6 e 65 69 e 15 10 e B: 1
T: 2
H: 2
B: 4
T: 3
e 0 0
Nealon et al 2002 187/66 (all patients) 46 (all patients) e NR NR e NR NR e 0 0
Nq et al 1998 NR NR NR NR NR NR NR NR NR NR NR NR 0 0 0
Pan et al 2015 210/200 NR 197/180 57 NR 58 7.8 NR 6.7 H: 94
B: 176
T: 138
U: 2
NR H: 76
B: 160
T: 97
U: 44
0 0 0
Rana et al 2015 21/5 e 20/5 35.4 (all patients) 10.8 (all patients) NR NR NR 26 e 25
Redwan et al 2017 1.3/1 e L: 1/1
O: 1.5/1
49.2 e L: 51.8
O: 48.8
10.3 e L: 10.1
O: 9.9
NR e NR 0 e 0
Saluja et al 2016 (abstract) NR NR NR NR NR NR 11 NR 14.2 NR NR NR NR NR NR
Saul et al 2015 13/21 NR 29/43 44.4 NR 40 6.7 NR 10 H: 21
B: 43
T: 31
0 0 0
Siddiqui et al 2017 (abstract) NR e NR NR e NR NR e NR NR NR NR 42 e 39
Spofford et al 2011 (abstract) 5/7 e 11/4 50 e 52 NR e NR B: 6
HeB: 1
T: 1
B-T: 1
E: 2
EP: 1
H: 1
B: 2
B-T: 1
E: 5
EP: 6
12 e 15
Tan et al 2018 (abstract) 193/154 46.85 NR H: 129
B/T: 218
0 0 0
Varadarajulu et al 2013 12/8 e 16/4 48 e 51 NR e NR NR e NR 0 e 0
Varadarajulu et al 2008 6/4 e 15/5 43.1 e 42.3 8.9 e 9.8 H: 2
B:1
T: 4
M: 3
H: 2
B: 3
T: 10
M: 5
0 e 0
L. Szako et al. / Pancreatology 20 (2020) 132e141 135which favored ED. Clinical success (OR¼ 2.84; 95% CI 0.90, 8.98;
p¼ 0.076, I2¼ 74.8%, p¼ 0.019) and complications (OR¼ 0.87; 95%
CI 0.31, 2.43; p¼ 0.787, I2¼ 0.0%, p¼ 0.737) did not differ signiﬁ-
cantly between the two interventional methods (Fig. 1/B).Surgical versus endoscopic intervention
Pseudocysts and walled-of necroses
Fourteen articles compared ED and SD (including 842 and 896
patients, respectively) [17e19,21e32]. Among these articles, six
reported data about mortality [17,21e25], thirteen about clinical
Fig. 1. A: Comparison of percutaneous and endoscopic drainage including both type of ﬂuid collections, B: Comparison of the endoscopic and percutaneous drainage including only
pseudocysts regarding mortality, recurrence, clinical success and complications.
L. Szako et al. / Pancreatology 20 (2020) 132e141136success [18,19,21e25,27e32], ten about recurrence [17e19,21,22,
24,26e29], ten about adverse events [18,22e25,27,28,30e32], ﬁve
about postoperative [22,23,30e32], two about total LOH [23,27],
and three about cost [22,23,27].
Signiﬁcant difference was found in postoperative LOH (WMD
(days)¼4.61; 95%CI -7.89, 1.33; p¼ 0.006, I2¼ 93.5%, p< 0.001)
and at the total LOH (WMD (days)¼3.67; 95%CI -5.00, 2.34;
p< 0.001, I2¼ 75.2%, p¼ 0.045), which favored endoscopic inter-
vention (Fig. 2/A).
Clinical success of ED was lower than SD (OR¼ 0.59; 95% CI 0.37,
0.93; p¼ 0.022, I2¼19.2%, p¼ 0.250), but mortality (OR¼ 0.86;
95% CI 0.15, 5.06; p¼ 0.870, I2¼ 0.0%, p¼ 0.378), recurrence
(OR¼ 1.79; 95% CI 0.93, 3.35; p¼ 0.068, I2¼ 27.2%, p¼ 0.211),
complication rate (OR¼ 0.75; 95% CI 0.45, 1.25; p¼ 0.264, I2¼ 3.4%,
p¼ 0.406), and cost (WMD (USD)¼3683.54; 95%CI
-7723.38, 356.30; p¼ 0.074, I2¼ 98.7%, p< 0.001) were similar
concerning the two methods (Supplemental Figure 3-4).
Pseudocysts
Eleven articles compared endoscopic drainage with surgery
(including 739 and 797 patients respectively) including only
pseudocysts [17e19,21,22,24,27,29e32]. Among them four studies
compared mortality [17,21,22,24], eight recurrence [17e19,21,22,
24,27,29], ten clinical success [18,19,21,22,24,27,29e32], seven
complications [18,22,24,27,30e32], four the postoperative LOH
[22,30e32]. Signiﬁcant difference could be stated regarding clinical
success (OR¼ 0.54; 95% CI) 0.35, 0.85; p¼ 0.007, I2¼13.1%,
p¼ 0.322) and recurrence (OR¼ 1.80; 95% CI 1.16, 2.79; p¼ 0.009,
I2¼ 0.0%, p¼ 0.456), both favored SD. Mortality (OR¼ 0.86; 95% CI
0.15, 5.06; p¼ 0.870, I2¼ 0.0%, p¼ 0.378), complications
(OR¼ 0.82; 95% CI 0.44, 1.51; p¼ 0.523, I2¼10.6%, p¼ 0.248) and
LOH (WMD (days)¼5.07; 95%CI -11.26, 1.12; p¼ 0.109,
I2¼ 94.2%, p< 0.001) did not differ signiﬁcantly (Fig. 2/B,
Supplemental Figure 5).
Walled-off necroses
Four articles compared endoscopic drainage with surgery
(including 100 and 99 patients respectively) regarding only walled-
off necroses [23,25,26,28]. Among these, two compared mortality
[23,25], two recurrence [26,28], three clinical success [23,25,28],three complications [23,25,28]. There was no signiﬁcant difference
between the two interventional methods regarding mortality
(death did not occur in the two interventional methods), clinical
success (OR¼ 1.01; 95%CI 0.23, 4.43; p¼ 0.990, I2¼ 40.1%,
p¼ 0.188), recurrence (OR¼ 0.8; 95%CI 0.03, 18.72; p¼ 0.889,
I2¼ 75.0%, p¼ 0.046), complications (OR¼ 0.56; 95%CI 0.19, 1.71;
p¼ 0.311, I2¼14.6%, p¼ 0.310) (Supplemental Figure 6). There
were not enough articles comparing the LOH and cost.
Minimal invasive surgery versus endoscopic drainage including both
pseudocysts and walled-off necroses
Five articles compared the endoscopic drainage with minimal
invasive surgery (including 172 and 103 patients respectively)
[23,24,28,29,31]. Two articles compared the mortality [23,24],
three the recurrence [24,28,29], ﬁve the clinical success
[23,24,28,29,31], four the complications [23,24,28,31]. There was
no difference between minimal invasive surgical or endoscopic
drainage regarding mortality (no death occurred), clinical success
(OR¼ 0.53; 95%CI 0.19, 1.49; p¼ 0.232, I2¼ 37.3%, p¼ 0.172),
recurrence (OR¼ 2.7; 95%CI 0.44, 16.54; p¼ 0.281, I2¼ 0.00%,
p¼ 0.559) or complications (OR¼ 0.68; 95%CI 0.28, 1.16; p¼ 0.377,
I2¼ 0.00%, p¼ 0.831) (Supplemental Figure 7).
Minimal invasive surgery versus endoscopic drainage including only
pseudocysts
Three articles compared endoscopic drainage with minimal
invasive surgery including only patients with pseudocysts (110 and
44 patients respectively) [24,29,31]. Among these, one article was
concerned mortality [24], two with recurrence [24,29], three with
clinical success [24,29,31] and two with complications [24,31].
There was no signiﬁcant difference regarding mortality, clinical
success (OR¼ 0.48; 95%CI 0.11, 2.13; p¼ 0.332, I2¼ 53.8%,
p¼ 0.115), recurrence (OR¼ 1.29; 95%CI 0.06, 28.09; p¼ 0.873) and
complications (OR¼ 0.47; 95%CI 0.14, 1.61; p¼ 0.230, I2¼ 0.00%,
p¼ 0.648) (Supplemental Figure 8).
Minimal invasive surgery versus endoscopic drainage including only
walled-off necroses
Two articles compared endoscopic intervention with minimal
invasive surgery including only patients with walled-off necroses
Fig. 2. A: Comparison of the endoscopic and surgical drainage regarding length of hospitalisation including both type of ﬂuid collections, B: Comparison of the endoscopic and
surgical drainage including only pseudocysts regarding mortality, recurrence, clinical success and complications.
L. Szako et al. / Pancreatology 20 (2020) 132e141 137(62 and 59 patients, respectively) [23,28]. Among these one was
concerned with mortality [23], one with recurrence [28], two with
clinical success [23,28], two with complications [23,28]. There was
no signiﬁcant difference regarding mortality (no death occurred),
recurrence (OR¼ 4.00; 95%CI 0.43, 37.46; p¼ 0.225), clinical suc-
cess (OR¼ 0.6.; 95%CI 0.08, 4.72; p¼ 0.625, I2¼ 50.8%, p¼ 0.154)
and complications (OR¼ 0.97; 95%CI 0.28, 3.31; p¼ 0.963,
I2¼ 0.00%, p¼ 0.952) (Supplemental Figure 9).
Surgical versus percutaneous drainage including both pseudocysts
and walled-off necroses
Eleven articles compared the outcomes of PD and SD (including
8530 and 7300 patients, respectively) [17e19,21,33e39], among
them seven reported data on mortality [33e38], six on clinical
success [19,21,35e37,39], six on recurrence [17e19,35,36,38], ﬁve
on adverse events [18,33,37e39] and two LOH [34,36].
Recurrence rate (OR¼ 4.91; 95% CI 1.82, 13.22; p¼ 0.002,
I2¼ 66.5%, p¼ 0.011), and clinical success rate (OR¼ 0.13; 95% CI
0.07, 0.22, p< 0.001, I2¼ 0.0%, p¼ 0.774) was signiﬁcantly better in
SD compared to PD (Fig. 3). Mortality (OR¼ 2.23; 95%CI 0.81, 6.15
p¼ 0.120, I2¼ 31.2%, p¼ 0.213), complications rate (OR¼ 1.27 95%
CI 0.28, 5.82; p¼ 0.759, I2¼ 79.8%, p¼ 0.001) and LOH (WMD
(days)¼ 16.49 95% CI -4.09, 37.07; p¼ 0.074, I2¼ 98.7, p< 0.001)
did not differ in the twomodalities (Fig. 3, Supplemental Figure 10).
The results are summarized in Table 3.
Discussion
Percutaneous drainage provided inferior outcomes compared to
endoscopic intervention in our analysis. Clinical success was
signiﬁcantly higher in the ED group. Comparing pseudocysts only,
signiﬁcantly fewer recurrence occurred after ED. There were not
enough articles comparing walled-off necroses only.Surgery provides higher clinical success and lower recurrence
rate than PD. Percutaneous ﬁstulas were responsible for majority of
the complications of the percutaneous treatment.
Finally, the shorter LOH makes endoscopic interventions favor-
able over surgery. Although SD had higher success rate and lower
recurrence rate than ED in cases of pseudocysts, although therewas
a signiﬁcant heterogeneity in both outcomes. The two modalities
seem to be equally efﬁcient regarding other outcomes. Cost of
intervention also did not differ signiﬁcantly between the two
methods, although independently both Varadarajulu et al in 2013
[27] and Saul et al in 2015 [22] reported, that endoscopic inter-
vention is more cost effective. Khreiss et al in 2015 [23] reported
equal amount of cost. The study of Varadarajulu et al. from 2008
[32] could not be included in our analysis, as it did not report
standard deviation, but it also reported lower cost of the endo-
scopic intervention. Including walled-off necroses only, signiﬁcant
difference could not be found between surgery and endoscopy.
Signiﬁcant difference could neither be found comparing minimal
invasive surgery with endoscopic drainage.
Two important RCT comparing surgical and endoscopic treat-
ment of WON was not included in our analysis, because 40e80% of
patients in the PENGUIN trial [40] and all patients randomized to
the surgical group in the TENSION trial [41] had PD procedures as
the ﬁrst step in their treatment. Furthermore, these trials recruited
critically ill patient with proven or highly suspected infected ne-
crosis, which best treated probably by the step-up approach [41].
A meta-analysis comparing endoscopic drainage and surgery
was carried out earlier, which included four randomized controlled
trials [42]. Three of the included articles compared different
endoscopic methods, therefore, we could not include in our anal-
ysis [43e45]. It also found, that endoscopic intervention was
associated with shorter LOH, which was also shown by our analysis.
Another meta-analysis comparing endoscopic drainage with
percutaneous drainage was also carried out [10], which concluded,
Fig. 3. Comparison of the surgical and percutaneous drainage including both type of ﬂuid collections regarding mortality, recurrence, clinical success and complications.
Table 3
Summary of the results of the statistical analysis. NS¼ no signiﬁcant difference. Comparison between ED and PD including onlyWON, and the comparison between PD and SD
including only PC and only WON were not possible due to lack of studies.
All ﬂuid collection only PC only WON
ED versus PD Recurrence NS ED is better e
Clinical success ED is better NS
NS in Mortality, Complications, Length of hospitalisation
ED versus SD Clinical success SD is better SD is better NS
Recurrence NS SD is better NS
Length of hospitalisation ED is better NS NS
NS in Mortality, Complications
ED versus minimal invasive SD NS in Mortality, Recurrence, Clinical success, Complications and Length of hospitalisation
PD versus SD Recurrence SD is better e e
Clinical success SD is better
NS in Mortality, Complications and Length of hospitalisation
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cess, adverse events, and LOH. This meta-analysis included three
additional articles, which were dealing with ﬂuid collections after
pancreatic surgery, therefore, we did not include them in our
analysis [46e48].
A systematic review was also carried out comparing ED with
minimal invasive, laparoscopic intervention [49]. According to this
review, laparoscopic intervention is associated with higher clinical
success and less adverse events compared to endoscopic drainage,
although the authors emphasize that the heterogeneity is
signiﬁcant.
Another systematic review was carried out including non-
comperative articles [50]. This review also concluded that endo-
scopic drainage is preferable over percutaneous drainage, although
in certain group of patients one method might be more feasible
over the others. The analysis also highlights, that direct comparison
cannot be carried out sometimes due to the signiﬁcant heteroge-
neities of the articles, which is also supported by our analysis.
Considering and summarizing our results and also incorporating
the current scientiﬁc view of the treatment of pancreatic ﬂuid
collections, we propose a protocol for the treatment of pancreatic
ﬂuid collections (Fig. 4). The proper intervention for symptomatic
pancreatic ﬂuid collections can be chosen according to the location-
based approach. If the location of the ﬂuid collection allows
different interventional modalities, the step-up approach can be
applied. The endoscopic drainage seems to be the most effective
and less invasive procedure in this treatment algorithm.Fig. 4. Suggested protocol for the treatment of pancreatic ﬂuid collections. (PFC¼ panLimitations
The overall quality of evidence (GRADE) is very low (Supple-
mental, Multimedia Component 3). The heterogeneity is consider-
able in some of the outcomes. Our analysis included only 2
randomized clinical trials. Most of the studies had few numbers of
patients. There was a difference between the number of patients
comparing endoscopic and percutaneous drainage. Furthermore,
we did not perform a subgroup analysis concerning the different
types of endoscopic drainage. The six abstracts, which provided
enough data to the analysis also carries a high risk of bias. Signiﬁ-
cant heterogeneity was found at multiple outcomes, which lowers
the grade of evidence. The deﬁnition of clinical success differed
between studies, but 13 out of the 24 studies deﬁned it as radio-
logical resolution. Six studies did not deﬁne clinical success. The
length of follow-up period after intervention also varied, the
shortest follow up was 3 month (in 2 studies), the longest follow up
period was 38 months, while it was not speciﬁed in 11 studies. We
included only English language studies.Conclusion
The treatment of inﬂammatory pancreatic ﬂuid collections is
strongly inﬂuenced by local expertise and radiological ﬁndings,
such as location and size of the collection. Surgery, percutaneous
drainage and endoscopic intervention are all accepted treatment
modalities and each method has a speciﬁc group of patients, wherecreatic ﬂuid collection, white arrows indicate the suggested site of intervention).
L. Szako et al. / Pancreatology 20 (2020) 132e141140it is more favorable over the other types of interventions.
According to our meta-analysis, endoscopic intervention and
surgery seems to be equally efﬁcient, although endoscopic mo-
dalities provide shorter LOH. Percutaneous drainage is less favor-
able than the other two modalities. This outcomes are also
supported by a previousmeta-analysis [10] and a systematic review
[50]. To eliminate the signiﬁcant heterogeneity and to provide a
higher level of evidence, an objective reporting system and further
prospective randomized multicenter studies are needed.
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